Check Point Software Technologies heads into its July 24 print with the short build from earlier in the month plateauing, but the analyst community more divided than it has been all year.
Short interest has effectively stopped growing. From a rapid climb to roughly 6.3 million shares in mid-July, estimated shorts edged back to around 6.2 million by July 17 — down fractionally on the day and still up 19% on the week, but the acceleration has paused. The lending market remains nowhere near stressed: availability runs at 608%, meaning there are roughly six shares available to borrow for every one already lent out, and cost to borrow holds at just 0.54%, up from last month but still firmly in "easy borrow" territory. Options positioning has also eased from the more defensive posture flagged earlier in the week. The put/call ratio came in at 0.49 on Monday, barely a quarter of a standard deviation above its 20-day average of 0.47 — call demand is holding its own, and the pre-earnings hedging that appeared in mid-July has not intensified further.
The more interesting tension is in analyst positioning. Two upgrades hit in early July — Guggenheim moved to Buy with a $188 target, Scotiabank to Sector Outperform at $185 — pointing to conviction that the stock's post-April selloff was overdone. Then Raymond James pulled back to Market Perform on July 15, and Wells Fargo this morning raised its target to $140 while holding at Equal-Weight, a move that reads more as catch-up housekeeping than a ringing endorsement. The mean analyst target now sits at $147, about 8% above the current price of $135.73. Bulls focus on genuine growth in security subscriptions, SASE and CTEM demand, and a pipeline that looks healthy despite the go-to-market disruption. Bears point to the same GTM restructuring as an execution risk, a pattern of weak new customer acquisition, and a stock that has rallied 11% in a month heading into a quarter where guidance is still under pressure.
The last earnings report, on April 30, produced an 18% one-day drop and a 17% five-day decline — the sharpest reaction in recent memory — after the company missed revenue expectations and cut full-year guidance. The stock has clawed back most of that ground since, rising roughly 11% over the past month to $135.73. That recovery itself raises the stakes: the Street has repriced the risk in, but execution on the GTM overhaul needs to show at least stabilisation to justify the bounce.
Thursday's print is therefore a test of whether the recovery in Check Point's revenue trajectory is real, or whether the stock has simply run ahead of a business that is still working through its restructuring.
See the live data behind this article on ORTEX.
Open CHKP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
